Freeline Therapeutics Holdings plc(NASDAQ:FRLN) 
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is FLT180a, a gene therapy product cand...
Website: https://www.freeline.life/
Founded: 2015
Full Time Employees: 200
CEO: Anne Prener
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-08-22
P
O 4.43
H 4.43
L 4.20
C 4.20
V 13,352
10EMA 4.20
20EMA 4.20
60EMA 4.20
120EMA 4.20
250EMA 4.20